<DOC>
	<DOCNO>NCT00234832</DOCNO>
	<brief_summary>The purpose study determine long-term effect sibutramine treatment cardiovascular outcome overweight obese patient risk cardiovascular event .</brief_summary>
	<brief_title>A Long Term Study Sibutramine Role Obesity Management Relation Cardiovascular Disease Overweight Obese Patients</brief_title>
	<detailed_description>The study consist 4 period : 1 ) Screening Period approximately 2 week ; 2 ) 6-week Lead-in Period , subject receive single-blind sibutramine country-specific standard care weight management . Subjects discontinue study drug treatment Lead-in Period randomize participate double-blind Treatment Period Follow-up Period ; 3 ) double-blind Treatment Period subject randomize 1 2 treatment group follow study end ; 4 ) double-blind Follow-up Period , randomized subject discontinue study drug follow study end . The Randomization Phase consist double-blind Treatment Period double-blind Follow-up Period . Subjects receive country-specific standard care weight management Randomization Phase . An independent event adjudication committee evaluate potential cardiovascular outcome event confirm outcome event time onset include statistical analysis .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Sibutramine</mesh_term>
	<criteria>Subject 's body mass index ( BMI ) &gt; = 27 kg/m ( 2 ) &lt; = 45 kg/m ( 2 ) BMI &gt; = 25 kg/m ( 2 ) &lt; 27 kg/m ( 2 ) waist circumference &gt; = 102 cm male &gt; = 88 cm female . Medical history positive : Preexisting cardiovascular disease ( i.e. , coronary artery disease , cerebrovascular disease , peripheral arterial occlusive disease ) and/or Type 2 diabetes mellitus least 1 risk factor ( i.e. , dyslipidemia , control hypertension , current smoker , diabetic nephropathy evidence microalbuminuria ) History recent myocardial infarction . Heart failure symptom great New York Heart Association Functional Class II . Hemodynamically significant valvular leave ventricular ( LV ) tract obstruction . Subjects without pacemaker following : Sinus bradycardia ( &lt; 50 bpm ) Sick sinus syndrome Atrioventricular block 1st degree Mean sit systolic blood pressure ( SBP ) &gt; 160 mmHg . Mean sit diastolic blood pressure ( DBP ) &gt; 100 mmHg . Mean sit heart rate ( HR ) &gt; 100 bpm . Syncopal episodes presume due uncontrolled lifethreatening arrhythmia . Planned cardiac surgery coronary angioplasty within 6 month screen . History recent nonhemorrhagic stroke transient ischemic attack ( TIA ) , history hemorrhagic stroke . Hyperthyroidism . Known chronic liver disease endstage renal disease . Severe , symptomatic benign prostatic hyperplasia may require surgery . Known pheochromocytoma , history narrow angle glaucoma , Gilles de la Tourette syndrome , history seizure , history bariatric abdominal obesity surgery ( exclude liposuction ) . Concomitant use monoamine oxidase inhibitor drug increase level serotonin brain . Treated hypertension stabilize less 3 month . Inability perform regular physical activity .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Sibutramine</keyword>
</DOC>